Another company looking to initiate clinical trials with an epigenetic-editor-based treatment for hepatitis is nChroma Bio.

New legislation that the government says will cut UK Reach registration costs for chemical businesses by £40 million over the ...

UKRI has seen a cash terms increase in its budget in recent years, rising 14% from 2020–21 to £8.9 billion in 2024–25. But ...

A new light-activated catalyst breaks and resets carbon–halogen bonds to convert racemic mixtures into enantiomerically ...

A self-powered, bioresorbable temporary pacemaker the size of a grain of rice has been developed by an international team of ...

The next generation of genetically altered food is forging ahead, aiming to be attractive to consumers rather than producers.

Scientists in Spain have shown that spray-drying equipment can be used to perform three common organic reactions. The ...

For the first time, fermentation has been achieved in space. Miso made aboard the International Space Station (ISS) aged ...

The broad and variable trade tariffs introduced by US president Donald Trump are set to play havoc with complex chemical ...

Broad and high tariffs could mean severe job losses and supply chain disruption for chemistry-using industries ...

The first solution synthesis of the elusive ‘Clar’s goblet’ structure – first proposed over 50 years ago – has provided the ...